Non-clear cell renal cell carcinoma (nccRCC) (including papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma, unclassified renal cell carcinoma, FH-deficient renal cell carcinoma, SDHB-deficient renal cell carcinoma, TFE-3 fusion renal cell carcinoma, etc.)
Conditions
Interventions
A cohort of patients with non-clear cell renal cell carcinoma (nccRCC):no
Sponsors
Fuzhou University Affiliated Provincial Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with a postoperative pathological diagnosis of non-clear cell renal cell carcinoma (nccRCC), including but not limited to papillary renal cell carcinoma (pRCC), chromophobe renal cell carcinoma (chRCC), collecting duct carcinoma (CDC), medullary carcinoma, mucinous tubular spindle cell carcinoma (MTSCC), and unclassified renal cell carcinoma (uRCC); 2. Retain paraffin-embedded and/or frozen sections of tumor tissue and matching normal renal tissue adjacent to the tumor that meet quality requirements; 3. Complete and verifiable clinical and pathological data, as well as follow-up information, are available.
Exclusion criteria
Exclusion criteria: 1. Cases with significant gaps in clinical pathology or follow-up data that do not meet the requirements for analysis; 2. Cases where tumor tissue samples are deemed substandard following evaluation (e.g., excessive necrosis, insufficient tumor cell content);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cancer-specific survival;overall survival (OS); | — |
Countries
China
Contacts
Public ContactYe Liefu
Fuzhou University Affiliated Provincial Hospital
Outcome results
None listed